Lycorine inhibits lipopolysaccharide-induced iNOS and COX-2 up-regulation in RAW264.7 cells through suppressing P38 and STATs activation and increases the survival rate of mice after LPS challenge

Lycorine inhibits lipopolysaccharide-induced iNOS and COX-2 up-regulation in RAW264.7 cells through suppressing P38 and STATs activation and increases the survival rate of mice after LPS challenge
复制标题

Lycorine 通过抑制 P38 和 STAT 激活来抑制 RAW264.7 细胞中脂多糖诱导的 iNOS 和 COX-2 上调,并提高 LPS 攻击后小鼠的存活率

DOI:
10.1016/j.intimp.2011.11.018
复制
发表时间:
2012-01-01
影响因子:
5.6
通讯作者:
Yin, Zhimin
Yin, Zhimin
中科院分区:
医学2区
文献类型:
--
作者:
Kang, Jingjing;Zhang, Yushun;Yin, Zhimin

文献摘要

被引文献

相似文献

石蒜碱是从石蒜科植物中提取的一种天然生物碱,对肿瘤细胞具有多种生物学效应。石蒜碱剂量依赖性地抑制LPS诱导的RAW264.7细胞中一氧化氮合酶(iNOS)和环氧合酶-2(考克斯-2)蛋白水平的上调。此外,它还抑制LPS处理的RAW 264.7细胞释放NO、PGE(2)、TNF-α和IL-6。RT-PCR实验表明石蒜碱抑制LPS诱导的iNOS基因表达,但不抑制考克斯-2基因表达。此外,石蒜碱降低LPS诱导的小鼠死亡率。机制上,LPS诱导的P38和STATs通路的激活被石蒜碱显著抑制。石蒜碱不干扰ERK 1/2、JNK 1/2和NF-κ B通路的磷酸化。总之,石蒜碱抑制LPS诱导的促炎介质的产生,并增加LPS攻击后小鼠的存活率,表明石蒜碱可能在响应LPS中发挥抗炎作用。(C)2011 Elsevier B. V.保留所有权利。
As a natural alkaloid extracted from Amaryllidaceae, lycorine shows various biological effects on tumor cells. Here we show that lycorine dose-dependently inhibited the LPS-induced up-regulation of nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) protein level in RAW264.7 cells. Besides, it also inhibited NO, PGE(2), TNF-alpha and IL-6 release from LPS-treated RAW264.7 cells. RT-PCR experiments showed that lycorine suppressed LPS-induced iNOS but not COX-2 gene expression. Moreover, lycorine decreased LPS-induced mortality in mice. Mechanistically, LPS-induced activation of P38 and STATs pathways was suppressed significantly by lycorine. In addition, lycorine did not interfere with the phosphorylation of ERK1/2, JNK1/2 and NF-kappa B pathways. In conclusion, lycorine inhibits LPS-induced production of pro-inflammatory mediators and increases the survival rate of mice after LPS challenge, suggesting that lycorine could play an anti-inflammatory role in response to LPS. (C) 2011 Elsevier B.V. All rights reserved.